la revision

65
LA REVISION - I Dr.V.RAMKUMAR CONSULTANTDENTAL&FACIOMAXILLARYSURGE REGNO:4118 TAMILNADU-INDIA(ASIA)

Upload: vasanramkumar

Post on 01-Jun-2015

154 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: La revision

LA REVISION - I

Dr.V.RAMKUMARCONSULTANTDENTAL&FACIOMAXILLARYSURGEON

REGNO:4118 TAMILNADU-INDIA(ASIA)

Page 2: La revision

Local anesthesia has been defined as a loss of sensation in a circumscribed area of the body caused by a depression of excitation in nerve endings or an inhibition of the conduction process in peripheral nerves.

Page 3: La revision

Properties deemed most desirable for a LA solution –

It should not be irritating to the tissue. It should not cause any permanent

alteration of nerve structure. Its systemic toxicity should be low. It must be effective regardless of whether

it is injected into the tissue or applied locally to mucous membranes.

Page 4: La revision

The time of onset of anesthesia should be as short as possible.

The duration of action must be long enough to permit completion of the procedure.

It should be relatively free from producing allergic reactions.

It should be stable in solution and readily undergo biotransformation in the body.

Page 5: La revision

Electrophysiology of nerve conduction

Page 6: La revision

Exitation of nerve segment leads to an increase in permeability of the cell membrane to Na ions

At firing threshold permeability increases dramatically

Page 7: La revision

Reversed polarity

Repolarization (the action potential is terminated)

Page 8: La revision

Mode and site of action of LA

LA interfere with the excitation process in a nerve membrane in one or more of the following ways

Altering the basic resting potential of the nerve membrane

Altering the threshold potential (firing level) Decreasing the rate of depolarization Prolonging the rate of repolarization

Page 9: La revision

Where do local anesthetics work?

Various theories –

Acetylcholine theory

Calcium displacement theory (most popular)

Surface charge (repulsion) theory

Membrane expansion theory

Specific receptor theory

Page 10: La revision

How LA work?

Page 11: La revision

Ca++ which exist in bound form within the cell membrane are thought to exert a regulatory role on the movement of Na+ ions

Ca++Ca++

Ca++Ca++

Displacement of Ca++ ions from the Na+ channel receptor site

Page 12: La revision

Binding of LA molecule to this receptor site produces –

Blockade of the Na+ channel –

and results in conduction blockade

Page 13: La revision

Pharmacology of LA

Page 14: La revision

Classification of LA

1…Esters

Benzoic acid Paraaminobenzoic acid

ButacaineCocaineEthyl aminobenzoate (benzocaine)HexylcainePiperocaineTetracaine

ChlouopeocaineProcainePropoxycaine

Page 15: La revision

2…Amides Articaine Bupivacaine Dibucaine Etidocaine Lidocaine Mepivacaine Prilocaine Ropivacaine

3…Quinoline Centbucridine

Page 16: La revision

Half life of LA Lidocaine – 1.6 hours

Bupivacaine – 3.5 hours

Page 17: La revision

Pharmacology of vasoconstrictors

Page 18: La revision

Vasoconstrictors are drugs that constrict blood vassals.

Advantages – Decreases blood flow to the site of

administration. Absorption of LA into the CVS is slowed. Minimizing the risk of LA toxicity. Increasing the duration of action of LA.

Page 19: La revision

Classification

Catecholamines Noncatecholamines

EpinephrineNorepinephrineLevonordefrin

AmphetamineMethamphetaminePhenylephrine

Felypressin (vasoconstrictor), a synthetic analogue of the polypeptide vasopressin.

Page 20: La revision

Maximum doses of LA Lidocaine with epinephrine

7 mg/kg of body weight for the adult (not to exceed a dose of 500 mg).

Lidocaine without epinephrine 4.4 mg of body weight for the adult (not to

exceed a dose of 300 mg).

Same dose for children.

Page 21: La revision

Calculation of number of cartridges (for70 kg)

Lidocaine with epinephrine

According to manufacturer –

20 mg/ml i.e. in 1 ml - 20 mg Considering cartridge as 1.8 ml

i.e. in 1.8 ml - 36mg(1.8×20)

or in 1 Cartridge - 36 mg Not to exceed a dose of 500 mg

So total no of cartridges 500/36 = 13.88 cartridges

Page 22: La revision

Lidocaine without epinephrine

According to manufacturer –

20 mg/ml i.e. in 1 ml - 20 mg Considering cartridge as 1.8 ml

i.e. in 1.8 ml - 36mg(1.8×20)

or in 1 Cartridge - 36 mg Not to exceed a dose of 300 mg

So total no of cartridges 300/36 = 8.33 cartridges

Page 23: La revision

Armamentarium

Page 24: La revision

Tow types of armamentarium

Major components

Syringe Needle Cartridge

Other components

Topical antiseptic Topical anesthetic Applicator sticks Cotton gauze (2×2

inches) Hemostat

Page 25: La revision

Syringe – It is the vehicle whereby the contents of the

anesthetic cartridge are delivered through the needle to the patient.

Page 26: La revision

Needle –The needle permits the local anesthetic

solution to travel from the dental cartridge into the tissues surrounding the needle tip.

Page 27: La revision

Cartridge – Is a glass cylinder containing the local

anesthetic drug.

Page 28: La revision

Topical anesthetic -

Page 29: La revision

Applicator sticks –

Page 30: La revision

Cotton gauze (2×2 inches) –

Page 31: La revision

Hemostat –

Page 32: La revision

LA REVISION – II

Page 33: La revision

Types of Local anesthetic injection

Local infiltration – Small terminal nerve endings in the area of the

dental treatment are flooded with local anesthetic solution.

Example: administration of LA into an interproximal papilla.

Page 34: La revision

Field block –LA solution is deposited near the larger

terminal nerve branches so the anesthetic area will be circumscribed.

Page 35: La revision

Nerve block –LA is deposited close to a main nerve trunk.

Page 36: La revision

Common Techniques of Anesthesia (Maxillary / Mandible)

1…Supraperiosteal (infiltration)2…Periodontal ligament injection

(intraligamentary injection)

Page 37: La revision

3…Intraseptal

Page 38: La revision

4…Intracrestal

5…Intraosseous

Page 39: La revision

Posterior superior alveolar nerve block

Techniques of maxillary anesthesia

Page 40: La revision

Infraorbital nerve block

Page 41: La revision

Middle superior alveolar nerve block Is present in only about 28% of the

population

Page 42: La revision

Palatal anesthesia Greater palatine nerve block

Page 43: La revision

Nesopalatine nerve block

Page 44: La revision

Techniques of mandibular anesthesia Inferior alveolar nerve block

Page 45: La revision

Lingual nerve block –

After depositing LA solution for inferior alveolar nerve pull the needle half way out, aspirate and deposit the LA solution for lingual nerve

Advantage – nicking of soft tissue will be avoided.

Page 46: La revision

Buccal nerve block –a. Parallel with occlusal plane on the side of

injection but buccal to it.b. Distal and buccal to the last molar.

Page 47: La revision

Mental nerve block

Page 48: La revision

Mandibular nerve block: the GOW-GATES technique

Page 49: La revision

VAZIRANI-AKINOSI closed-mouth mandibular block

Page 50: La revision

Complications of local anesthesia Local complications Needle breakage Persistent anesthesia or

paresthesia Facial nerve paralysis Trismus Soft-tissue injury Hematoma Pain on injection Burning on injection Infection Edema Sloughing of tissues Post-anesthetic intraoral

lesions

Systemic complications Vasodepressor syncope Over dosage (toxic

reaction) Allergy Psychogenic reactions

Page 51: La revision

Local complications

Page 52: La revision

Needle breakage

Causes – Weakening of the dental needle by

bending it before it’s insertion. Sudden unexpected movement by the

patients.

Prevention – Use a 25-gauge needle. Use long needle requiring penetration (>

18 mm).

Page 53: La revision

Persistent anesthesia or paresthesia

Causes – Trauma to any nerve. Injection of contaminated LA solution. Hemorrhage into or around the neural

sheath (Bleeding increases pressure on the nerve)

Prevention – Strict adherence to injection protocol. Proper care and handling of dental

cartridges.

Page 54: La revision

Causes – Transient facial nerve paralysis is commonly caused by

the introduction of LA into the capsule of the parotid gland.

Prevention – Adhering to protocol with the IANB . A needle tip should be in contact with the bone.

Management – Reassure the patient Contact lance should be removed An eye patch should be applied to the affected eye. “tincture of time” is the recommended medicine.

Page 55: La revision

TrismusCauses – Trauma to muscles or blood vessels. Contaminated LA solution. Hemorrhage. A low grade infection. Excessive volumes of LA solution.

Prevention – Practice atraumatic insertion and injection technique.

Management – Heat therapy, physiotherapy. Warm saline rinses. Anti-inflammatory, Analgesics, Muscle relaxants,

Antibiotics.

Page 56: La revision

Soft-tissue injury

Causes – Common in younger children and mentally or

physically disabled children or adults.

Prevention – Proper instruction and education of guardian

Page 57: La revision

HematomaCauses – The effusion blood into extravascular spaces due to

nicking of blood vessel (artery or vein) during injection.

Prevention – Use a short needle for PSA nerve block. Minimize number of needle penetration.

Management – Direct pressure should be applied to the site of

bleeding. Do not apply heat to the area for at least 4 to 6 hours.

Page 58: La revision

Pain on injection

Causes – Careless injection technique.

Prevention - Proper technique. Use of sharp needle. Use of topical anesthetic. Inject LA slowly.

Page 59: La revision

Burning on injection

Causes – pH of the solution (pH = 5 acidic) Rapid injection of LA. Contamination of LA cartridges

Prevention – Slowing the injection ( ideal rate 1 mm per sec.)

Page 60: La revision

InfectionCauses – Contamination of needle. Injecting LA solution into an area of infection.

Management – Rx treatment consist of those procedures to

manage Trismus.

Page 61: La revision

EdemaSwelling of tissue is a clinical sign of the presence

of some disorder.

Causes – Trauma, Infection, Allergy, Hemorrhage.

Prevention – Complete medical evaluation of the patient

before drug administration.

Page 62: La revision

Sloughing of tissues Prolonged irritation or ischemia of gingival

soft tissue may led to – Epithelial desquamation Sterile abscess

Page 63: La revision

Post-anesthetic intraoral lesions

These are recurrent aphthous stomatitis and Herpes simplex.

Management – Primary management is symptomatic.

Page 64: La revision

Systemic complications Vasodepressor syncope Over dosage (toxic reaction) Allergy Psychogenic reactions

Page 65: La revision

Thank You